Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Fennec Pharmaceuticals In...

    NASDAQ: FENC · Real-Time Price · USD
    7.75
    -0.42 (-5.14%)
    At close: Jun 17, 2025, 3:26 PM

    Fennec Pharmaceuticals Statistics

    Share Statistics

    Fennec Pharmaceuticals has 27.62M shares outstanding. The number of shares has increased by 1% in one year.

    Shares Outstanding

    n/a
    		 27.62M

    Shares Change (YoY)

    n/a
    		 1%

    Shares Change (QoQ)

    n/a
    		 0.61%

    Owned by Institutions (%)

    n/a
    		 58.63%

    Shares Floating

    n/a
    		 23.03M

    Failed to Deliver (FTD) Shares

    n/a
    		 1,644

    FTD / Avg. Volume

    n/a
    		 1.83%

    Short Selling Information

    The latest short interest is 1.42M, so 5.16% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 1.42M

    Short % of Shares Out

    n/a
    		 5.16%

    Short % of Float

    n/a
    		 7.46%

    Short Ratio (days to cover)

    n/a
    		 9.85

    Valuation Ratios

    The PE ratio is -395.64 and the forward PE ratio is 9.48. Fennec Pharmaceuticals's PEG ratio is 4.06.

    PE Ratio

    n/a
    		 -395.64

    Forward PE

    n/a
    		 9.48

    PS Ratio

    n/a
    		 3.63

    Forward PS

    n/a
    		 1.4

    PB Ratio

    n/a
    		 -31.33

    P/FCF Ratio

    n/a
    		 6.39

    PEG Ratio

    n/a
    		 4.06
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Fennec Pharmaceuticals.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 6.38, with a Debt / Equity ratio of -3.51.

    Current Ratio

    n/a
    		 6.38

    Quick Ratio

    n/a
    		 6.22

    Debt / Equity

    n/a
    		 -3.51

    Debt / EBITDA

    n/a
    		 5.37

    Debt / FCF

    n/a
    		 0.72

    Interest Coverage

    n/a
    		 0.63

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $1,485,562.5

    Profits Per Employee

    n/a
    		 $-13,625

    Employee Count

    n/a
    		 32

    Asset Turnover

    n/a
    		 1.06

    Inventory Turnover

    n/a
    		 3

    Taxes

    Income Tax

    n/a
    		 365K

    Effective Tax Rate

    n/a
    		 -514.08%

    Stock Price Statistics

    The stock price has increased by 18.65% in the last 52 weeks. The beta is 0.4, so Fennec Pharmaceuticals's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.4

    52-Week Price Change

    n/a
    		 18.65%

    50-Day Moving Average

    n/a
    		 6.68

    200-Day Moving Average

    n/a
    		 5.93

    Relative Strength Index (RSI)

    n/a
    		 59.98

    Average Volume (20 Days)

    n/a
    		 89,844

    Income Statement

    In the last 12 months, Fennec Pharmaceuticals had revenue of 47.54M and earned -436K in profits. Earnings per share was -0.02.

    Revenue

    n/a
    		 47.54M

    Gross Profit

    n/a
    		 44.35M

    Operating Income

    n/a
    		 2.57M

    Net Income

    n/a
    		 -436K

    EBITDA

    n/a
    		 3.6M

    EBIT

    n/a
    		 2.57M

    Earnings Per Share (EPS)

    n/a
    		 -0.02
    Full Income Statement

    Balance Sheet

    The company has 26.63M in cash and 19.34M in debt, giving a net cash position of 7.29M.

    Cash & Cash Equivalents

    n/a
    		 26.63M

    Total Debt

    n/a
    		 19.34M

    Net Cash

    n/a
    		 7.29M

    Retained Earnings

    n/a
    		 -219.68M

    Total Assets

    n/a
    		 46.4M

    Working Capital

    n/a
    		 34.6M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was 26.98M and capital expenditures 0, giving a free cash flow of 26.98M.

    Operating Cash Flow

    n/a
    		 26.98M

    Capital Expenditures

    n/a
    		 n/a

    Free Cash Flow

    n/a
    		 26.98M

    FCF Per Share

    n/a
    		 0.99
    Full Cash Flow Statement

    Margins

    Gross margin is 93.3%, with operating and profit margins of 5.4% and -0.92%.

    Gross Margin

    n/a
    		 93.3%

    Operating Margin

    n/a
    		 5.4%

    Pretax Margin

    n/a
    		 -0.15%

    Profit Margin

    n/a
    		 -0.92%

    EBITDA Margin

    n/a
    		 7.57%

    EBIT Margin

    n/a
    		 5.4%

    FCF Margin

    n/a
    		 56.75%

    Dividends & Yields

    FENC does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for FENC is $13, which is 60.9% higher than the current price. The consensus rating is "Strong Buy".

    Price Target

    n/a
    		 $13

    Price Target Difference

    n/a
    		 60.9%

    Analyst Consensus

    n/a
    		 Strong Buy

    Analyst Count

    n/a
    		 2
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on Sep 9, 2014. It was a backward split with a ratio of 1:3.

    Last Split Date

    n/a
    		 Sep 9, 2014

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:3

    Scores

    Altman Z-Score

    n/a
    		 -2.82

    Piotroski F-Score

    n/a
    		 1

    Add to Watchlist